Study the Variables Affecting Formulation of Ethylcellulose-based Microsponges Loaded with Clobetasol
DOI:
https://doi.org/10.31351/vol32issSuppl.pp225-234Keywords:
Clobetasol propionate, Ethylcellulose, encapsulation efficiency, kinetic modeling, microsponges, release profile, quasi emulsionAbstract
Clobetasol propionate (CP) is a super potent corticosteroid widely used to treat various skin disorders such as atopic dermatitis and psoriasis. However, its utility for topical application is hampered due to its common side effects, such as skin atrophy, steroidal acne, hypopigmentation, and allergic contact dermatitis. Microsponge is a unique three-dimensional microstructure particle with micro and nano-meters-wide cavities, which can encapsulate both hydrophilic and lipophilic drugs providing increased efficacy and safety. The aim of the current study is to prepare and optimize clobetasol-loaded microsponges. The emulsion solvent diffusion method is used for the preparation of ethylcellulose (EC)-based microsponges. The impact of various formulation variables on microsponge's properties includes; drug: polymer ratio, polyvinyl alcohol (PVA) quantities, the volume of external phase, and stirring rates investigated. The microsponges were characterized in terms of particle size, product yield, CP entrapment %, and in-vitro drug release behavior. The results report that increasing EC concentration led to a significant increase in particle size, with a decrease in product yield and drug entrapment %. Increasing stirring speed or external aqueous volume or PVA w/v % caused a non-significant decrease in production yield and CP entrapment % but showed a significant decrease, and increase in particle size, respectively. Finally, it was concluded that the ability to use ethylcellous as a Msg polymer matrix to prepare uniform, highly porous particles was confirmed by microscope observation and compatibility with CP.
References
Nidhi K, Verma S, Kumar S. Microsponge: An advanced drug delivery system. J Clin Sci Res.2021;10 (2):108.
Kadhim ZM, Mahmood HS, Alaayedi M, Ghareeb MM.Formulation of flurbiprofen as microsponge drug delivery. International Journal of Pharmaceutical Research. 2020; 12 (3); 748-753
Gunasheela S, V. Chandrakala, S. Srinivasan. Microsponge: An adaptable topical drug delivery system. World J Adv Res Rev. 2022;15(1):396–411.
Saxena S, Nacht S. Polymeric Porous Delivery Systems: Polytrap® and Microsponge®. In: Delivery System Handbook for Personal Care and Cosmetic Products; 2005. p. 333–51.
Jayasawal P, Rao NGR, Jakhmola V. Microsponge as Novel Drug Delivery System: A Review. Indo Glob J Pharm Sci. 2022; 12: 21–9.
Rajab NA, Jawad MS.Formulation and in vitro evaluation of piroxicam microsponge an a tablet. Int J Pharm Pharm Sci. 2016; 8 (2); 104-114.
Osmani RAM, Aloorkar NH, Ingale DJ, Kulkarni PK, Hani U, Bhosale RR, et al. Microsponges based novel drug delivery system for augmented arthritis therapy. Saudi Pharm J. 2015;23(5):562–72.
Nagula RL, Wairkar S. Cellulose microsponges based gel of naringenin for atopic dermatitis: Design, optimization, in vitro and in vivo investigation. Int J Biol Macromol. 2020;164:717–25.
Uva L, Miguel D, Pinheiro C, Antunes J, Cruz D, Ferreira J, et al. Mechanisms of Action of Topical Corticosteroids in Psoriasis. Int J Endocrinol. 2012;2012:1–16.
Schacke H. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther. 2002; 96(1): 23–43.
Moffat AC, Osselton MD, Widdop B. Clarkes's Analysis of Drugs and Poisons: in pharmaceuticals, body fluids and post-mortem material. 3rd Edition, Pharmaceutical Press; London, 2003, pp. 821
Tiwari A, Tiwari V, Palaria B, Kumar M, Kaushik D. Microsponges: a breakthrough tool in pharmaceutical research. Futur J Pharm Sci. 2022;8(1):31.
Alatraqchi FI, AL Gawhri FJ. Preparation and In-Vitro Evaluation as an Oral Microsponge Tablet of Baclofen. Iraqi J Pharm Sci. 2019;28(1):75–90.
Abdalla KF, Osman MA, Nouh AT, El Maghraby GM. Microsponges for controlled release and enhanced oral bioavailability of carbamazepine. J Drug Deliv Sci Technol. 2021;65:102683.
Sabri LA, A. Hussein A. Comparison Between Conventional and Supersaturable Self-nanoemulsion Loaded with Nebivolol: Preparation and In-vitro/Ex-vivo Evaluation. Iraqi J Pharm Sci. 2020;29(1):216–25.
Fahmy R, Kassem M. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: In vitro and in vivo evaluation. Eur J Pharm Biopharm. 2008;69(3):993–1003.
Kumar S, Prasad M, Rao R. Topical delivery of clobetasol propionate loaded nanosponge hydrogel for effective treatment of psoriasis: Formulation, physicochemical characterization, antipsoriatic potential and biochemical estimation. Mater Sci Eng C. 2021;119:111605.
Jasim I K, Abd Alhammid S N, Abdulrasool A A. Synthesis and evaluation of B-cyclodextrin Based Nanosponges of 5- Fluorouracil by Using Ultrasound Assisted Method. Iraqi J Pharm Sci. 2020; 29(2):88–98.
Rafat S, Singh LV. Formulation and evaluation of microsponges gel for topical use. World Journal of Pharmaceutical Research. 2017; 6 (16): 895-885.
Bothiraja C, Gholap AD, Shaikh KS, Pawar AP. Investigation of ethyl cellulose microsponge gel for topical delivery of eberconazole nitrate for fungal therapy. Ther Deliv. 2014;5(7):781–94.
Uddin R, Sansare V. Design, Fabrication and Evaluation of Ketorolac Tromethamine Loaded Microsponge Based Colon Targeted Tablet. Int J Adv Pharm Biotechnol. 2020 1;6(2):9–13.
Obiedallah MM, Abdel-Mageed AM, Elfaham TH. Ocular administration of acetazolamide microsponges in situ gel formulations. Saudi Pharm J. 2018; 26(7):909-920.
Yehia RM, Attia DA, Elmazar MM, El-Nabarawi MA, Teaima MH. Screening of Adapalene Microsponges Fabrication Parameters with Insight on the In vitro Biological Effectiveness. Drug Des Devel Ther. 2022 Nov 4;16:3847-3864.
Abd Alhammid SN. Enhacement of the solubility and the rate of candesartan cilexetil using microsponge technology. Asian J Pharm Clin Res. 2018 7;11(9):385.
Jafar M, Salahuddin M, Khan MSA, Alshehry Y, Alrwaili NR, Alzahrani YA, et al. Preparation and In Vitro-In Vivo Evaluation of Luteolin Loaded Gastroretentive Microsponge for the Eradication of Helicobacter pylori Infections. Pharmaceutics. 2021;13(12):2094.
Gunasheela S, Chandrakala V and Srinivasan S. Microsponge: An adaptable topical drug. World Journal of Advanced Research and Reviews, 2022, 15(01), 396–411.
Neamah W F , Maraie NK. Factors affecting preparation and evaluation of Kitorolac tromethamine microsponges for ocular use. Al Mustansiriyah Journal of Pharmaceutical Sciences, 2020; 20 (3): 58-70.
Shahzad Y, Saeed S, Ghori MU, Mahmood T, Yousaf AM, Jamshaid M, et al. Influence of polymer ratio and surfactants on controlled drug release from cellulosic microsponges. Int J Biol Macromol. 2018;109:963–70.
Deshmukh K, Poddar SS. Tyrosinase inhibitor-loaded microsponge drug delivery system: new approach for hyperpigmentation disorders. J Microencapsul. 2012; 29(6):559–68.
Nokhodchi A, Jelvehgari M, Siahi MR, Mozafari MR. Factors affecting the morphology of benzoyl peroxide microsponges. Micron. 2007;38(8):834–40.
Fareed NY, Kassab HJ. Studying the Effect of Variables on Acyclovir Microsponge. Iraqi J Pharm Sci. 2018 6;66–76.
Nief R A, Hussein AA. Preparation and Evaluation of Meloxicam Microsponges as Transdermal Delivery System. Iraqi J Pharm Sci. 2014;.23: 62-74.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512)
This work is licensed under a Creative Commons Attribution 4.0 International License.
